PointState Capital’s Amrize Ltd AMRZ Stock Holding History

PointState Capital’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-578,633	Closed	-$28.7M	–	69
2025 Q2	$28.7M	Buy	+578,633	New	+$29.2M	0.44%	42

Other funds holding AMRZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PointState Capital's AMRZ Position: Q3 2025 in Review

PointState Capital sold out of Amrize Ltd (AMRZ) in Q3 2025, closing a stake of 578,633 shares — an estimated $28.7M sold.

PointState Capital first reported a position in AMRZ in Q2 2025 and held it in 1 quarter. The position peaked at $28.7M in Q2 2025. 315 funds tracked by Wall St. Rank hold AMRZ as of Q3 2025.

PointState Capital reported no remaining Amrize Ltd position as of Q3 2025 after selling out during the quarter.
PointState Capital sold 578,633 Amrize Ltd shares in Q3 2025, an estimated $28.7M.
PointState Capital first reported a position in Amrize Ltd in Q2 2025 and held it in 1 quarter.
PointState Capital's Amrize Ltd position peaked at $28.7M in Q2 2025.
315 funds tracked by Wall St. Rank held Amrize Ltd as of Q3 2025.

Based on PointState Capital's 13F filing for Q3 2025, filed 14 Nov 2025.